Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Only 2-4 healthy messages per week can have a positive impact….
Read More »The Shift from T1 to T2 in the Youth Population
Is diagnosis of type 2 more dangerous in youth?…
Read More »Insulin/Liraglutide Combo in Type 2 Diabetes
A potential new treatment option for T2 diabetes….
Read More »Insulin Glargine U300 versus Lantus
New preliminary data is in…. Sanofi, the maker of Lantus (insulin glargine), finished more phase III studies on their newest formulation of insulin glargine, U300, and discussed their results at the World Diabetes Congress 2013 in early December. The study results have not yet been published but researchers reported that the …
Read More »Liraglutide and Pancreatitis/Pancreatic Cancer Risk
Post market study results….
Read More »Diet Drinks and Cardiometabolic Disease
What the studies really say….
Read More »All Fruits Not Created Equal
Blueberries, grapes, and apples may show benefit in type 2 diabetes….
Read More »Pros and Cons of Pioglitazone
Should it be used in treating type 2 diabetes?…
Read More »Global Diabetes Awareness in Primary Care
Is it enough?…
Read More »DPP-4 Inhibitors in the Elderly
Tolerability in type 2 diabetes patients aged 65 years and older….
Read More »